HEALTHEURACTIV
Belgium’s medicines paradox: pharma giant, but a desert for new drugs [Advocacy Lab]
Belgium is a major pharmaceutical producer but faces a paradox where drugs made there are unavailable to local patients. Pharma industry leaders highlight this discrepancy, noting that drugs produced on one side of the street are inaccessible to patients on the other.
Related Signal
Adjacent reporting
- Medication shortage chaos: The vital drugs missing from Britain's pharmacy shelves - and experts warn the issue is about to get WORSE
- STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis finds
- STAT+: European Union inks a draft deal to boost local production of medicines and avoid shortages
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
- Hiltzik: This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people
- From Sick Care to Healthcare